Javascript must be enabled to continue!
Insights into the mechanism of METTL3-mediated m6A methylation in silicon dust-induced epithelial-mesenchymal transition
View through CrossRef
Silicosis is an occupational lung disease caused by long-term inhalation of silica dust. Its characteristic pathological manifestation is progressive pulmonary fibrosis. Epithelial-mesenchymal transition (EMT) plays an important role in the occurrence and development of silicosis fibrosis, and N6-methyladenosine (m6A), as an important form of RNA modification, is closely related to the expression and regulation of multiple genes in the process of fibrosis. In the present study, we demonstrated that m6A modification significantly increases during silica-induced EMT. Silencing Methyltransferase Like 3 (METTL3) to reduce m6A modification levels inhibited the EMT process, suggesting that METTL3-mediated m6A modification could be an effective strategy for intervening in pulmonary fibrosis. Subsequently, through RNA sequencing, protein–protein interaction network analysis, and Methylated RNA Immunoprecipitation-RT-qPCR, we identified c-Myc as a downstream target of METTL3. In summary, our findings illuminate the relationship between m6A modification, METTL3, and the progression of silicosis, particularly through the EMT process. These results suggest that targeting METTL3 could be a promising therapeutic approach for modulating m6A levels and intervening in the progression of silicosis.
Title: Insights into the mechanism of METTL3-mediated m6A methylation in silicon dust-induced epithelial-mesenchymal transition
Description:
Silicosis is an occupational lung disease caused by long-term inhalation of silica dust.
Its characteristic pathological manifestation is progressive pulmonary fibrosis.
Epithelial-mesenchymal transition (EMT) plays an important role in the occurrence and development of silicosis fibrosis, and N6-methyladenosine (m6A), as an important form of RNA modification, is closely related to the expression and regulation of multiple genes in the process of fibrosis.
In the present study, we demonstrated that m6A modification significantly increases during silica-induced EMT.
Silencing Methyltransferase Like 3 (METTL3) to reduce m6A modification levels inhibited the EMT process, suggesting that METTL3-mediated m6A modification could be an effective strategy for intervening in pulmonary fibrosis.
Subsequently, through RNA sequencing, protein–protein interaction network analysis, and Methylated RNA Immunoprecipitation-RT-qPCR, we identified c-Myc as a downstream target of METTL3.
In summary, our findings illuminate the relationship between m6A modification, METTL3, and the progression of silicosis, particularly through the EMT process.
These results suggest that targeting METTL3 could be a promising therapeutic approach for modulating m6A levels and intervening in the progression of silicosis.
Related Results
Abstract 1737: METTL3-mediated m6A modification promotes tumor progression in upper tract urothelial carcinoma
Abstract 1737: METTL3-mediated m6A modification promotes tumor progression in upper tract urothelial carcinoma
Abstract
Upper tract urothelial carcinoma (UTUC), comprising 5% of urothelial neoplasms, is a rare malignancy arising from the transitional epithelium of the renal p...
The m6A Methyltransferase METTL3 Promotes Cisplatin Resistance and Invasion in Testicular Seminoma via BCL2
The m6A Methyltransferase METTL3 Promotes Cisplatin Resistance and Invasion in Testicular Seminoma via BCL2
Abstract
Background: Methyltransferase-like 3 (METTL3) involves in promoting tumor progression through tumor-related genes N6-methyladenosine (m6A) modification. Our previo...
METTL3 shapes m6A epitranscriptomic landscape for successful human placentation
METTL3 shapes m6A epitranscriptomic landscape for successful human placentation
AbstractMethyltransferase-like 3 (METTL3), the catalytic enzyme of methyltransferase complex for m6A methylation of RNA, is essential for mammalian development. However, the import...
Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation
Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation
Abstract
Background: Epigenetic reprogramming has been reported to play a critical role in the progression of thyroid cancer (TC). RNA methylation accounts for more than 60...
METTL3 silencing suppresses cardiac fibrosis via m6A modification of SMOC2
METTL3 silencing suppresses cardiac fibrosis via m6A modification of SMOC2
Abstract
Cardiac fibrosis leads to decreased cardiac compliance, impaired systolic and diastolic function, resulting in heart failure. M6A methylation plays a role in fibro...
N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
Abstract
Background
Polycystic ovary syndrome (PCOS) is a multisystem-related disease whose pathophysiology is still unclear. Several regulators of ...
Prognostic value of comprehensive typing based on m6A and gene cluster
Prognostic value of comprehensive typing based on m6A and gene cluster
Abstract
Background
Triple-negative breast cancer (TNBC) is resistant to targeted therapy with HER2 monoclonal antibodies and endocrine therapy because it lacks the estrog...
N6-methyladenosine-mediated Nrf2 Regulates the Defense Mechanism Against PM2.5-induced Pulmonary Fibrosis
N6-methyladenosine-mediated Nrf2 Regulates the Defense Mechanism Against PM2.5-induced Pulmonary Fibrosis
Abstract
Background: It has been reported that particulate matter with an aerodynamic diameter of < 2.5 µm (PM2.5) could induce epithelial–mesenchymal transition (EMT)- ...

